Publications

Publications

Barua N, Bienemann A, Gill S.
Convection-enhanced delivery of gene therapies to the pons - a novel method of achieving transgene expression throughout the Central Nervous System. American Society of Gene and Cell Therapy Annual Meeting; New Orleans, LA: May 13-17, 2025.​
Barua N, Bienemann A, Gill S
Sub-motor Cortex Convection-enhanced Delivery of AAV5-GDNF – a Novel Treatment Strategy for Amyotrophic Lateral Sclerosis. American Society of Gene and Cell Therapy Annual Meeting; New Orleans, LA: May 13-17, 2025.​
Barua N, Bienemann A, Gill S.
Convection-enhanced delivery of gene therapies to the pons - a novel method of achieving transgene expression throughout the Central Nervous System. American Society of Gene and Cell Therapy Annual Meeting; New Orleans, LA: May 13-17, 2025.​
Barua N, Gill S
Drug Delivery for Movement Disorders. Prog Neurol Surg. 2018;33:243-252. doi: 10.1159/000481108. Epub 2018 Jan 12. PMID: 29332088.​
Singleton WGB, Bienemann AS, Woolley M, Johnson D, Lewis O, Wyatt MJ, Damment SJP, Boulter LJ, Killick-Cole CL, Asby DJ, Gill SS.
The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. J Neurosurg Pediatr. 2018 Sep;22(3):288-296. doi: 10.3171/2018.2.PEDS17663. Epub 2018 Jun 1. Erratum in: J Neurosurg Pediatr. 2018 Oct 12;23(1):133. doi: 10.3171/2018.9.PEDS17663a. PMID: 29856296.​
Lewis O, Woolley M, Johnson D, Rosser A, Barua NU, Bienemann AS, Gill SS, Evans S.
Chronic, intermittent convection-enhanced delivery devices. J Neurosci Methods. 2016 Feb 1;259:47-56. doi: 10.1016/j.jneumeth.2015.11.008. Epub 2015 Nov 23. PMID: 26617320.
Barua NU, Gill SS, Love S.
Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations. Brain Pathol. 2014 Mar;24(2):117-27. doi: 10.1111/bpa.12082. Epub 2013 Sep 11. PMID: 23944716; PMCID: PMC8028869.
​ Arshad A, Yang B, Bienemann AS, Barua NU, Wyatt MJ, Woolley M, Johnson DE, Edler KJ, Gill SS.
Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma. PLoS One. 2015 Jul 17;10(7):e0132266. doi: 10.1371/journal.pone.0132266. PMID: 26186224; PMCID: PMC4506141.

We often send out our newsletter with news and great offers. We will never disclose your data to third parties and you can unsubscribe from the newsletter at any time.

Unfortunately, we’re unable to offer free samples. As a retailer, we buy all magazines from their publishers at the regular trade price. However, you could contact the magazine’s publisher directly to ask if they can send you a free copy.

You can create a new account at the end of the order process or on the following page. You can view all of your orders and subscriptions in your customer account. You can also change your addresses and your password.

No, you don’t have to create an account. But there are a few advantages if you create an account.

  • You never have to enter your billing and shipping address again

  • Find all of your orders, subscriptions and addresses in your account

  • Download invoices of your orders

No, we don’t have a physical store location at the moment. We accept only orders through our online shop and we’re shipping all orders with the Swiss Post Service. Please visit our shipping section for more details.

From time to time you will find us at design fairs and popup markets in Switzerland. Subscribe to our newsletter and you’ll receive the latest news.

Tab Content

This is a basic text element.
© 2025 Neurochase
Privacy Policy